1. Make PCA fail-safe

   News item 09 February 2013 Pages: 2 - 2

2. Norflox/‘Norflex’ confusion

   Correspondence 09 February 2013 Pages: 2 - 2

3. Bepridil safety: European and US experience

   Symposium 09 February 2013 Pages: 3 - 3

4. Continuing the fluoxetine debate

   Comment 09 February 2013 Pages: 3 - 3

5. Fluoxetine and the curse of the media

   Case report 09 February 2013 Pages: 3 - 3

6. Acamprosate

   Case report 09 February 2013 Pages: 4 - 4

7. The mechanism of enuresis with urapidil discussed

   Comment 09 February 2013 Pages: 4 - 4

8. Trazodone overdose effects disputed

   News item 09 February 2013 Pages: 4 - 4

9. Anaesthetics

   Case report 09 February 2013 Pages: 5 - 5

10. Antipsychotics

    Incidence study 09 February 2013 Pages: 5 - 5

11. Benzodiazepines overdose

    Incidence study 09 February 2013 Pages: 5 - 5

12. Bezafibrate

    Case report 09 February 2013 Pages: 5 - 5

13. Brofaromine interaction

    Volunteers 09 February 2013 Pages: 5 - 5

14. Budesonide

    Case report 09 February 2013 Pages: 6 - 6

15. Carbamazepine

    Case report 09 February 2013 Pages: 6 - 6

16. Carboplatin

    Incidence study 09 February 2013 Pages: 6 - 6

17. Colchicine

    Case report 09 February 2013 Pages: 6 - 6

18. Corticosteroids

    Volunteers 09 February 2013 Pages: 6 - 6

19. Cotrimoxazole

    Incidence study 09 February 2013 Pages: 6 - 6

20. Cyclophosphamide

    Case report 09 February 2013 Pages: 7 - 7

21. Cyclophosphamide

    Case report 09 February 2013 Pages: 7 - 7

22. Diazepam

    Case report 09 February 2013 Pages: 7 - 7

23. Dithranol

    Case report 09 February 2013 Pages: 7 - 7

24. Doxorubicin

    Case report 09 February 2013 Pages: 7 - 7

25. Flecainide interaction

    Clinical study 09 February 2013 Pages: 7 - 7

26. Flecainide overdose

    Case report 09 February 2013 Pages: 7 - 7

27. Fluconazole

    Case report 09 February 2013 Pages: 7 - 7

28. Ginseng

    Animal 09 February 2013 Pages: 8 - 8

29. Ibuprofen

    Incidence study 09 February 2013 Pages: 8 - 8

30. Imipenem + cilastatin

    Case report 09 February 2013 Pages: 8 - 8

31. Immunotherapies

    Incidence study 09 February 2013 Pages: 8 - 8

32. Indomethacin withdrawal

    Case report 09 February 2013 Pages: 8 - 8

33. Interferon alpha C

    Case report 09 February 2013 Pages: 8 - 8

34. Interleukin 2

    Case reports 09 February 2013 Pages: 9 - 9

35. Lithium

    Case report 09 February 2013 Pages: 9 - 9

36. Lorazepam

    Case report 09 February 2013 Pages: 9 - 9

37. Measles mumps and rubella virus vaccine

    Case report 09 February 2013 Pages: 9 - 9

38. Measles, mumps and rubella virus vaccine

    Incidence study 09 February 2013 Pages: 9 - 9

39. Mefenamic acid

    Case reports 09 February 2013 Pages: 10 - 10

40. Methylprednisolone

    Case report 09 February 2013 Pages: 10 - 10

41. Mitomycin

    Case report 09 February 2013 Pages: 10 - 10

42. Nicotinic acid

    Case report 09 February 2013 Pages: 10 - 10

43. NSAIDs

    Case report 09 February 2013 Pages: 10 - 10

44. Octreotide

    Clinical study 09 February 2013 Pages: 10 - 10

45. Procainamide

    Case report 09 February 2013 Pages: 10 - 10

46. Dalteparin-sodium

    Clinical study 09 February 2013 Pages: 11 - 11

47. Quinidine

    Case report 09 February 2013 Pages: 11 - 11

48. Rifampicin

    Case report 09 February 2013 Pages: 11 - 11

49. Sotalol

    Case report 09 February 2013 Pages: 11 - 11

50. Tea-tree oil

    Case reports 09 February 2013 Pages: 11 - 11